Last reviewed · How we verify
Iohexol renal clearance measurement
At a glance
| Generic name | Iohexol renal clearance measurement |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care (NA)
- The Practicality and Utility of Measured vs Estimated GFR in adCKD
- Evaluation of the Performance of Glomerular Filtration Rate Measurement Using CT Urography in Patients With a GFR Below 60 mL/Min/1.73 m² (NA)
- Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease (NA)
- Effect of Hormone Therapy on Renal Function
- Pilot Study DiaDEP (NA)
- Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
- PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iohexol renal clearance measurement CI brief — competitive landscape report
- Iohexol renal clearance measurement updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI